Similar articles for PMID: 31286752

Year	Number of Results
1988	1
1994	1
1995	2
1998	1
1999	1
2000	2
2001	4
2003	2
2005	1
2006	1
2007	3
2009	5
2010	4
2011	4
2012	5
2013	8
2014	4
2015	7
2016	12
2017	7
2018	9
2019	9
2020	2
2022	1
2023	1
2024	0

1

Molecular imaging of bone metastases using bone targeted tracers.

Vaz S, Usmani S, Gnanasegaran G, Van den Wyngaert T. Vaz S, et al. Q J Nucl Med Mol Imaging. 2019 Jun;63(2):112-128. doi: 10.23736/S1824-4785.19.03198-4. Epub 2019 Jul 8. Q J Nucl Med Mol Imaging. 2019. PMID: 31286752 Review.

2

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

3

Molecular imaging of bone metastases using tumor-targeted tracers.

Karamzade-Ziarati N, Manafi-Farid R, Ataeinia B, Langsteger W, Pirich C, Mottaghy FM, Beheshti M. Karamzade-Ziarati N, et al. Q J Nucl Med Mol Imaging. 2019 Jun;63(2):136-149. doi: 10.23736/S1824-4785.19.03206-0. Epub 2019 Jul 16. Q J Nucl Med Mol Imaging. 2019. PMID: 31315347 Review.

4

Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.

Bombardieri E, Setti L, Kirienko M, Antunovic L, Guglielmo P, Ciocia G. Bombardieri E, et al. Q J Nucl Med Mol Imaging. 2015 Dec;59(4):381-99. Epub 2015 Sep 3. Q J Nucl Med Mol Imaging. 2015. PMID: 26337240 Free article. Review.

5

Molecular Imaging of Bone Metastases and Their Response to Therapy.

Cook GJR, Goh V. Cook GJR, et al. J Nucl Med. 2020 Jun;61(6):799-806. doi: 10.2967/jnumed.119.234260. Epub 2020 Apr 3. J Nucl Med. 2020. PMID: 32245899 Free article. Review.

6

A Prospective Study Comparing ^99mTc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with ¹⁸F-Fluoride PET/CT and ¹⁸F-Fluoride PET/MRI for Diagnosing Bone Metastases.

Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM. Löfgren J, et al. J Nucl Med. 2017 Nov;58(11):1778-1785. doi: 10.2967/jnumed.116.189183. Epub 2017 Aug 10. J Nucl Med. 2017. PMID: 28798033 Free article.

7

The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer.

Kulshrestha RK, Vinjamuri S, England A, Nightingale J, Hogg P. Kulshrestha RK, et al. J Nucl Med Technol. 2016 Dec;44(4):217-222. doi: 10.2967/jnmt.116.176859. Epub 2016 Sep 15. J Nucl Med Technol. 2016. PMID: 27634981 Free article. Review.

8

Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment.

Cook GJ, Azad GK, Goh V. Cook GJ, et al. J Nucl Med. 2016 Feb;57 Suppl 1:27S-33S. doi: 10.2967/jnumed.115.157867. J Nucl Med. 2016. PMID: 26834098 Free article. Review.

9

Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.

Chua S, Gnanasegaran G, Cook GJ. Chua S, et al. Semin Nucl Med. 2009 Nov;39(6):416-30. doi: 10.1053/j.semnuclmed.2009.07.002. Semin Nucl Med. 2009. PMID: 19801221 Review.

10

Atlas of Extraosseous Findings Detected by 18F-NaF PET/CT Bone Scan.

Woodhead GJ, Avery RJ, Kuo PH. Woodhead GJ, et al. Clin Nucl Med. 2017 Dec;42(12):930-938. doi: 10.1097/RLU.0000000000001861. Clin Nucl Med. 2017. PMID: 29036001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year